Mostrar el registro sencillo del ítem
In Vitro Antifungal Activities of Isavuconazole and Comparators against Rare Yeast Pathogens
dc.contributor.author | Guinea, Jesús | |
dc.contributor.author | Recio, Sandra | |
dc.contributor.author | Escribano, Pilar | |
dc.contributor.author | Pelaez, Teresa | |
dc.contributor.author | Gama, Beatriz | |
dc.contributor.author | Bouza, Emilio | |
dc.date.accessioned | 2024-02-06T10:13:52Z | |
dc.date.available | 2024-02-06T10:13:52Z | |
dc.date.issued | 2010-06-21 | |
dc.identifier.citation | Guinea, J., Recio, S., Escribano, P., Peláez, T., Gama, B., & Bouza, E. (2010). In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogens. Antimicrobial agents and chemotherapy, 54(9), 4012–4015. https://doi.org/10.1128/AAC.00685-10 | es |
dc.identifier.issn | 0066-4804 | |
dc.identifier.other | https://journals.asm.org/journal/aac | es |
dc.identifier.uri | http://hdl.handle.net/20.500.12020/1222 | |
dc.description.abstract | We compared the in vitro activities of isavuconazole, posaconazole, voriconazole, and fluconazole against Dipodascus capitatus (n = 21), Saccharomyces cerevisiae (n = 20), Rhodotorula mucilaginosa (n = 18), and Trichosporon spp. (n = 15). The MIC(50)s, MIC(90)s, and MIC ranges (in microg/ml) obtained using the CLSI M27-A3 procedure were as follows: isavuconazole, 0.125, 0.5, and < or = 0.015 to 2; posaconazole, 0.5, 2, and < or = 0.015 to > 16; voriconazole, 0.125, 2, and < or = 0.015 to 8; and fluconazole, 4, > 128, and < or = 0.125 to > 128. Isavuconazole showed potent activity against the isolates studied | es |
dc.language.iso | en | es |
dc.publisher | American Society for Microbiology | es |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | In Vitro Antifungal Activities of Isavuconazole and Comparators against Rare Yeast Pathogens | es |
dc.type | article | es |
dc.identifier.doi | 10.1128/AAC.00685-10 | |
dc.issue.number | 9 | es |
dc.journal.title | Antimicrobial Agents and Chemotherapy | es |
dc.page.initial | 4012 | es |
dc.page.final | 4015 | es |
dc.relation.projectID | This study was partially financed by grants from Basilea Pharmaceutica International Ltd. and by grants from the Fondo de Investigacio´n Sanitaria (FIS) PI070198 (Instituto de Salud Carlos III). | es |
dc.rights.accessRights | embargoedAccess | es |
dc.subject.area | Ciencias Biomédicas | es |
dc.subject.keyword | Candida | es |
dc.subject.keyword | Isavuconazole | es |
dc.subject.keyword | Antifungal activity | es |
dc.subject.keyword | Non-candida | es |
dc.subject.keyword | Candidemia | es |
dc.subject.keyword | Yeasts | es |
dc.subject.keyword | Antifungal activity | es |
dc.subject.unesco | 2414 Microbiología | es |
dc.volume.number | 54 | es |
Ficheros en el ítem
Fichero/s | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |